Novavax's COVID-flu combo and standalone flu shots improve immunity in late-stage study
Jun 11, 2025 4:30 AM
(Reuters) -Novavax's ( NVAX ) experimental COVID-19-influenza combination and standalone influenza vaccines showed strong immune responses in some patients tested in a late-stage study, the company said on Wednesday.
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations,
you may see comments from our Community Managers.